Skip to main content


Table 1 Characteristics of the included guidelines.

From: Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines

Guideline identifier, year released Guideline developer and country Disease or condition Guideline title
Cardiovascular disease and related condition
NCEP, 2002
(updated 2004) [10, 14]
National Heart, Lung, and Blood Institute, US Hypercholesterolemia and coronary heart disease National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
NICE1, 2006 [15] National Institute for Health and Clinical Excellence, UK Cardiovascular disease Statins for the Prevention of Cardiovascular Events
AHA1, 2006 [16] American Heart Association and American Stroke Association, US Ischemic stroke Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council
AHA2, 2007 [17] American Heart Association, US Cardiovascular disease Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update
MSC1, 2008 [18] Medical Services Commission, British Columbia, Canada Cardiovascular disease Cardiovascular Disease - Primary Prevention
NICE2, 2008 [19] National Collaborating Centre for Primary Care, UK Cardiovascular disease Lipid Modification. Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease
ACCP, 2008 [20] American College of Chest Physicians, US Coronary artery disease The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
MSC2, 2008 [21] Medical Services Commission, British Columbia, Canada Hypertension Hypertension - Detection, Diagnosis and Management
USPSTF, 2009 [22] U.S. Preventive Services Task Force, US Cardiovascular disease Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement
UMHS1, 2009 [23] University of Michigan Health System, US Coronary heart disease and stroke Screening and Management of Lipids
ICSI, 2009 [24] Institute for Clinical Systems Improvement, US dyslipidemia and coronary heart disease Lipid Management in Adults
MQIC, 2009 [25] Michigan Quality Improvement Consortium, US Hypercholesterolemia Screening and Management of Hypercholesterolemia
Cardiovascular disease and type 2 diabetes
ES, 2008 [26] The Endocrine Society, US Cardiovascular disease and Type 2 diabetes Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
Type 2 diabetes
NICE3, 2008 [27] National Clinical Guideline Centre for Acute and Chronic Conditions, UK Type 2 diabetes Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (update)
MSC3, 2010 [28] Medical Services Commission, British Columbia, Canada Type 2 diabetes Diabetes Care
ADA, 2011 [29] American Diabetes Association, US Type 2 diabetes Standards of Medical Care in Diabetes - 2011
Breast cancer
UMHS2, 2007 [30] University of Michigan Health System, US Breast cancer Common Breast Problems
NSGC, 2007 [31] National Society of Genetic Counselors, US Breast cancer and ovarian cancer Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer: Recommendations of the National Society of Genetic Counselors
ASCO, 2009 [32] American Society of Clinical Oncology, US Breast cancer American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction
NICE4, 2009 [33] National Collaborating Centre for Cancer, UK Breast cancer Early and Locally Advanced Breast Cancer. Diagnosis and Treatment